骨髓增生异常综合征中国诊断与治疗指南(2019年版)( 六 )


[5]BennettJM, CatovskyD, DanielMT, et al. Proposals for the classification of the myelodysplastic syndromes[J]. Br J Haematol, 1982, 51(2):189-199.
[6]GreenbergP, CoxC, LeBeauMM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes[J]. Blood, 1997, 89(6):2079-2088.
[7]MalcovatiL, DellaPMG, StruppC, et al. Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System(WPSS)[J]. Haematologica, 2011, 96(10):1433-1440. DOI: 10.3324/haematol.2011.044602.
[8]reenbergPL, TuechlerH, SchanzJ, et al. Revised international prognostic scoring system for myelodysplastic syndromes[J]. Blood, 2012, 120(12):2454-2465. DOI: 10.1182/blood-2012-03-420489.
[9]ValentP, OraziA, SteensmaDP, et al. Proposed minimal diagnostic criteria for myelodysplastic syndromes(MDS)and potential pre-MDS conditions[J]. Oncotarget, 2017, 8(43):73483-73500. DOI: 10.18632/oncotarget.19008.
中华医学会血液学分会 中华血液学杂志, 2019,40(2) : 89-97. DOI: 10.3760/cma.j.issn.0253-2727.2019.02.001
记得收藏转发朋友圈 , 手有余香 。
【骨髓增生异常综合征中国诊断与治疗指南(2019年版)】关注我 , 了解更多医学科普知识 。


推荐阅读